1.Expression of recombinant cytolethal distending toxin of Actinobacillus actinomycetemcomitans.
Shu MENG ; He YANG ; Lei ZHAO ; Ya-Fei WU
Chinese Journal of Stomatology 2009;44(7):409-412
OBJECTIVETo examine the expression of recombinant cytolethal distending toxin (CDT) produced by Actinobacillus actinomycetemcomitans (Aa).
METHODSCDT encoding gene cdtABC was amplified by PCR. Through TA clone and restriction endonuclease digestion, gene cdtABC and vector pQE60 were ligated to form pQE60-cdtABC expression system which transformed into competent cells. Protein expression was induced by IPTG and examined by SDS-PAGE and Western-blotting.
RESULTSRandom colony PCR of pQE60-cdtABC transformed cells demonstrated that all strains contained cdtABC gene. The DNA sequence was blast with cdtABC gene from GenBank and 99% homology was obtained. SDS-PAGE and Western-blotting confirmed that recombinant CDT was obtained.
CONCLUSIONSCDT protein expression system was reconstructed and recombinant protein was obtained. Actinobacillus actinomycetemcomitans;
Aggregatibacter actinomycetemcomitans ; genetics ; metabolism ; Bacterial Toxins ; genetics ; metabolism ; Genetic Vectors ; Recombinant Proteins ; genetics ; metabolism
2.Transcriptomic analysis of the ΔPaLoc mutant of Clostridioides difficile and verification of its toxicity.
Gu Zhen CUI ; Qing Shuai ZHOU ; Qin Quan CHENG ; Feng Qin RAO ; Yu Mei CHENG ; Yan TIAN ; Ting ZHANG ; Zheng Hong CHEN ; Jian LIAO ; Zhi Zhong GUAN ; Xiao Lan QI ; Qi WU ; Wei HONG
Chinese Journal of Preventive Medicine 2022;56(5):601-608
Objective: Comparative analyses of wild-type Clostridioides difficile 630 (Cd630) strain and pathogenicity locus (PaLoc) knockout mutant (ΔPaLoc) by using RNA-seq technology. Analysis of differential expression of Cd630 wild-type strain and ΔPaLoc mutant strain and measurement of its cellular virulence changes. Lay the foundation for the construction of an toxin-attenuated vaccine strain against Clostridioides difficile. Methods: Analysis of Cd630 and ΔPaLoc mutant strains using high-throughput sequencing (RNA-seq). Clustering differentially expressed genes and screening differentially expressed genes by DESeq software. Further analysis of differential genes using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. Finally, cytotoxicity assays of ΔPaLoc and Cd630 strains were performed in the African monkey kidney epithelial cell (Vero) and the human colonic cell (Caco-2) lines. Results: The transcriptome data showed that the ΔPaLoc mutant toxin genes tcdA and tcdB were not transcribed. Compared to the wild-type strain, CD630_36010, CD630_020910,CD630_02080 and cel genes upregulated 17.92,11.40,8.93 and 7.55 fold, respectively. Whereas the hom2 (high serine dehydrogenase), the CD630_15810 (spore-forming protein), CD630_23230 (zinc-binding dehydrogenase) and CD630_23240 (galactitol 1-phosphate 5-dehydrogenase) genes were down-regulated by 0.06, 0.075, 0.133 and 0.183 fold, respectively. The GO and KEGG enrichment analyses showed that the differentially transcribed genes in ΔPaLoc were enriched in the density-sensing system, ABC transport system, two-component system, phosphotransferase (PTS) system, and sugar metabolism pathway, as well as vancomycin resistance-related pathways. Cytotoxicity assays showed that the ΔPaLoc mutant strain lost its virulence to Vero and Caco-2 cells compared to the wild-type Cd630 strain. Conclusion: Transcriptional sequencing analysis of the Cd630 and ΔPaLoc mutant strains showed that the toxin genes were not transcribed. Those other differential genes could provide a reference for further studies on the physiological and biochemical properties of the ΔPaLoc mutant strain. Cytotoxicity assays confirmed that the ΔPaLoc mutant lost virulence to Vero and Caco-2 cells, thus laying the foundation for constructing an toxin-attenuated vaccine strain against C. difficile.
Bacterial Proteins/metabolism*
;
Bacterial Toxins/metabolism*
;
Caco-2 Cells
;
Clostridioides
;
Clostridioides difficile/genetics*
;
Humans
;
Oxidoreductases/metabolism*
;
Transcriptome
;
Vaccines, Attenuated
3.Clinical significance of virulence-related genes of type III secretion system of Pseudomonas aeruginosa.
Chao ZHUO ; Lu-xia WANG ; Shu-nian XIAO ; Hong-yu LI ; Gui-xia QIU ; Nan-shan ZHONG
Chinese Journal of Burns 2010;26(5):354-359
OBJECTIVETo study the clinical significance of virulence genes exo U and exo S of type III secretion system (TTSS) of Pseudomonas aeruginosa (PA).
METHODSOne hundred and eighty-nine clinical isolates of PA were collected from five hospitals. The incidence of virulence genes exo U and exo S in PA were determined with PCR. Minimum inhibitory concentration of anti-bacterial drug for PA was determined with microdilution method. The clinical features and outcomes of 60 hospitalized patients colonized or infected with exo U+/exo S- positive or exo U-/exo S+ positive PA isolated from sputum were analyzed retrospectively. Data were processed with chi-square test.
RESULTSAmong the 189 PA isolates, 85.2% (161/189) harbored TTSS genes, including exo U-/exo S+ type (120 isolates), exo U+/exo S- type (31 isolates), exo U-/exo S- type (7 isolates), and exo U+/exo S+ type (3 isolates). 72.0% (72/100) isolates from sputum and 81.5% (44/54) isolates from blood belonged to exo U-/exo S+ genotype. Compared with those of TTSS-negative isolates, the antimicrobial resistance of TTSS-positive isolates to cefoperazone/sulbactam, ceftazidime, amikacin, and cefepime were lower (with χ² value respectively 10.1, 16.1, 9.3, 33.8, P values all below 0.01). The antimicrobial resistance to all examined drug between exo U-/exo S+ type and exo U+/exo S- type isolates was close (with χ² values from 0.08 to 2.04, P values all above 0.05). Patients detected with exo U+/exo S- positive PA isolated from sputum were significantly associated with PA infection, and they usually had history of tracheal intubation, ICU hospitalization, and combined use of drugs for anti-infection treatment. Patients detected with exo U-/exo S+ positive PA isolated from sputum were significantly associated with PA colonization, which had basic lung disease and better outcome than the former infection type.
CONCLUSIONSThe TTSS exists in most clinical isolates of PA. Detection of exo U or exo S of PA isolated from sputum is helpful for the analysis of clinical features and outcome of patients.
ADP Ribose Transferases ; genetics ; metabolism ; Bacterial Proteins ; genetics ; metabolism ; Bacterial Secretion Systems ; genetics ; Bacterial Toxins ; genetics ; metabolism ; Drug Resistance, Bacterial ; Genes, Bacterial ; Humans ; Microbial Sensitivity Tests ; Pseudomonas Infections ; microbiology ; Pseudomonas aeruginosa ; genetics ; isolation & purification ; pathogenicity ; Retrospective Studies ; Virulence
4.Construction and identification of the prokaryotic expression system of rLTB/rCTB-rOmpL1/1 fusion genes.
Ping RUAN ; Jie YAN ; Ya-fei MAO ; Shu-ping LI ; Yi-hui LUO ; Li-wei LI
Journal of Zhejiang University. Medical sciences 2005;34(1):21-26
OBJECTIVETo construct prokaryotic expression systems of ltB/ctB-ompL1/1 fusion genes and to determine the L.interrogans carrying status in leptospirosis patients with the expression products.
METHODSThe fusion genes ltB-ompL1/1 and ctB-ompL1/1 were constructed using linking primer PCR method. SDS-PAGE was used to examine expression of the target recombinant proteins rLTB-rOmpL1/1 and rCTB-rOmpL1/1. Western blot and GM1-ELISA were used to measure the immunogenic and GM(1)-binding activities of rLTB-rOmpL1/1 and rCTB-rOmpL1/1, respectively. PCR and MAT were performed to detect the expression of ompL1 gene in 97 wild L.interrogans strains. Antibodies against ompL1 gene products in serum samples of 228 leptospirosis patients were detected with ELISA method.
RESULTSThe homogeneity of nucleotide and putative amino acid sequence of ltB-jompL1/1 and ctB-ompL1/1 fusion genes were 99.7 % - 99.9 % and 99.5 % - 100 %, in comparison with the reported corresponding sequences. Expression outputs of both rLTB-rOmpL1/1 and rCTB-rOmpL1/1, mainly present in inclusion body, accounted for 10% of the total bacterial protein. Both rLTB-rOmpL1/1 and rCTB-rOmpL1/1 could combine to rabbit anti-rOmpL1/1 serum and bovine GM(1). 89.7 % of L.interrogans wild strains had ompL1 gene. 87.6% of the wild L.interrogans strains presented positive results for MAT (titers :1:4-1:256) with the rabbit anti-rOmpL1/1 or anti-rOmpL1/2 sera. 86.8% and 88.6% of the patients' serum samples were positive for rOmpL1/1 and rOmpL1/2 antibodies, respectively.
CONCLUSIONThe fusion proteins, rLTB-rOmpL1/1 and rCTB-rOmpL1/1, showed high immunogenic and GM(1)-binding activities. ompL1 gene is extensively distributed and frequently expressed in different serogroups of L.interrogans and its products expressed by different genotypes exhibit extensive cross-antigenicity.
Bacterial Outer Membrane Proteins ; genetics ; immunology ; Bacterial Toxins ; genetics ; Bacterial Vaccines ; genetics ; Cloning, Molecular ; Enterotoxins ; genetics ; Escherichia coli Proteins ; genetics ; Genes, Bacterial ; genetics ; Humans ; Leptospira interrogans ; genetics ; immunology ; Prokaryotic Cells ; metabolism ; Recombinant Fusion Proteins ; genetics ; immunology ; Vaccines, Synthetic ; genetics
5.Survival properties of ETEC surface-displayed K88ac-LT(B) on Lactobacillus casei.
Chunhua WEI ; Jiankui LIU ; Xilin HOU ; Guihua WANG ; Liyun YU
Chinese Journal of Biotechnology 2009;25(1):43-48
K88ac-LT(B) gene derived from pQE30-K88ac-LT(B) was cloned into the expression vector pLA and then the recombinant vector was transformed into the competent cells Lactobacillus casei 525. The recombinant bacteria were grown at 37 degrees C, in MRS broth. Western blotting analysis with rabbit-anti-K88ac-LT(B) polyclonal serum indicated that the recombinant protein reacted with the specific antibodies. The results showed that the molecular weight of the recombinant protein was about 71.2 kD. The K88ac-LT(B) fusion protein on the cell surface was confirmed by immunofluorescence mciroscopy and flow cytometric analysis. In addition, the survival of recombinant Lactobacillus casei 525 was studied in imitative gastrointestinal environments such as artificial gastro fluid (pH 1.5-5.5), artificial intestinal fluid, bile(0.3-3.0 g/L). The results indicated that the recombinant strain survived well in artificial gastric fluids at pH 2.5-4.5 in 5 h. The recombinant Lactobacillus casei 525 could slowly grow in the artificial intestinal fluid for different time, and could survive in 0.3% bile.
Antigens, Bacterial
;
genetics
;
Bacterial Toxins
;
genetics
;
metabolism
;
Enterotoxigenic Escherichia coli
;
genetics
;
metabolism
;
Enterotoxins
;
genetics
;
metabolism
;
Escherichia coli Proteins
;
genetics
;
metabolism
;
Fimbriae Proteins
;
genetics
;
Gastric Juice
;
Lactobacillus casei
;
genetics
;
metabolism
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
Recombination, Genetic
6.Type III secretion study of popN- mutant of Pseudomonas aeruginosa and proteases degradation.
Hong-Jiang YANG ; Dong-Sheng WEI ; Ming-Chun LI ; Lai-Jun XING
Chinese Journal of Biotechnology 2007;23(5):846-851
Pseudomonas aeruginosa is an important opportunistic human pathogen. It encodes many virulence factors and one of them is type III secretion system (TTSS). Effectors proteins can be delivered into host cells directly by this system, causing necrosis or apoptosis. popN gene is the first gene in the popN operon of TTSS gene cluster. To investigate its function, popN gene deletion mutant was generated in this study, and we found this mutant can secrete effectors proteins constitutively under non-inducting condition in DMEM medium containing serum. The results indicated that PopN is a negative regulator of the TTSS expression. However, no secreted effector proteins were detectable when the popN- mutant was grown in LB medium under non-inducting condition. To investigate the possible reasons, effects of growth status and protease (s) inhibitors on the TTSS were investigated. We present evidences that indicate protease mediated degradation of secreted effector proteins played a key role in the phenotypic inconsistency of popN- mutant.
ADP Ribose Transferases
;
metabolism
;
secretion
;
Bacterial Proteins
;
genetics
;
metabolism
;
secretion
;
Bacterial Toxins
;
metabolism
;
Gene Expression Regulation, Bacterial
;
Mutation
;
Peptide Hydrolases
;
genetics
;
metabolism
;
Pore Forming Cytotoxic Proteins
;
genetics
;
secretion
;
Protease Inhibitors
;
pharmacology
;
Pseudomonas aeruginosa
;
genetics
;
metabolism
;
pathogenicity
7.Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin.
Eun Jeong PARK ; Ji Hoon CHANG ; Jang Seong KIM ; Soo Il CHUNG ; Jung Sun YUM
Experimental & Molecular Medicine 1999;31(2):101-107
Escherichia coli heat-labile enterotoxin (LT) is composed of catalytic A and non-catalytic homo-pentameric B subunits and causes diarrheal disease in human and animals. In order to produce a nontoxic LT for vaccine and adjuvant development, two novel derivatives of LT were constructed by a site-directed mutagenesis of A subunit; Ser63 to Tyr63 in LTS63Y and Glu110, Glu112 were deleted in LT delta 110/112. The purified mutant LTs (mLTs) showed a similar molecular structural complex as AB5 to that of wild LT. In contrast to wild-type LT, mLTs failed to induce either elongation activity, ADP-ribosyltransferase activity, cAMP synthesis in CHO cells or fluid accumulation in mouse small intestine in vivo. Mice immunized with mLTs either intragastrically or intranasally elicited high titers of LT-specific serum and mucosal antibodies comparable to those induced by wild-type LT. These results indicate that substitution of Ser63 to Tyr63 or deletion of Glu110 and Glu112 eliminate the toxicity of LT without a change of AB5 conformation, and both mutants are immunogenic to LT itself. Therefore, both mLTs may be used to develop novel anti-diarrheal vaccines against enterotoxigenic E. coli.
Amino Acid Substitution
;
Animal
;
Bacterial Toxins/toxicity*
;
Bacterial Toxins/metabolism
;
Bacterial Toxins/immunology*
;
Bacterial Toxins/genetics
;
CHO Cells
;
Cyclic AMP/metabolism
;
Enterotoxins/toxicity*
;
Enterotoxins/metabolism
;
Enterotoxins/immunology*
;
Enterotoxins/genetics
;
Enzyme-Linked Immunosorbent Assay
;
Escherichia coli*/metabolism
;
Escherichia coli*/genetics
;
Female
;
Hamsters
;
IgA, Secretory/blood
;
Ileum/metabolism
;
Immunity, Mucosal
;
Mice
;
Mice, Inbred BALB C
;
Mutagenesis, Site-Directed
;
NAD+ ADP-Ribosyltransferase/metabolism
;
Recombinant Proteins/toxicity
;
Recombinant Proteins/metabolism
;
Recombinant Proteins/immunology
;
Recombinant Proteins/chemistry
8.Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples.
Abdullah KILIC ; Mohammad J ALAM ; Naradah L TISDEL ; Dhara N SHAH ; Mehmet YAPAR ; Todd M LASCO ; Kevin W GAREY
Annals of Laboratory Medicine 2015;35(3):306-313
BACKGROUND: The aim of this study was to develop and validate a multiplex real-time PCR assay for simultaneous identification and toxigenic type characterization of Clostridium difficile. METHODS: The multiplex real-time PCR assay targeted and simultaneously detected triose phosphate isomerase (tpi) and binary toxin (cdtA) genes, and toxin A (tcdA) and B (tcdB) genes in the first and sec tubes, respectively. The results of multiplex real-time PCR were compared to those of the BD GeneOhm Cdiff assay, targeting the tcdB gene alone. The toxigenic culture was used as the reference, where toxin genes were detected by multiplex real-time PCR. RESULTS: A total of 351 stool samples from consecutive patients were included in the study. Fifty-five stool samples (15.6%) were determined to be positive for the presence of C. difficile by using multiplex real-time PCR. Of these, 48 (87.2%) were toxigenic (46 tcdA and tcdB-positive, two positive for only tcdB) and 11 (22.9%) were cdtA-positive. The sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of the multiplex real-time PCR compared with the toxigenic culture were 95.6%, 98.6%, 91.6%, and 99.3%, respectively. The analytical sensitivity of the multiplex real-time PCR assay was determined to be 103colonyforming unit (CFU)/g spiked stool sample and 0.0625 pg genomic DNA from culture. Analytical specificity determined by using 15 enteric and non-clostridial reference strains was 100%. CONCLUSIONS: The multiplex real-time PCR assay accurately detected C. difficile isolates from diarrheal stool samples and characterized its toxin genes in a single PCR run.
ADP Ribose Transferases/genetics
;
Bacterial Proteins/*genetics
;
Bacterial Toxins/*genetics
;
Clostridium difficile/isolation & purification/*metabolism
;
DNA, Bacterial/genetics/metabolism
;
Enterotoxins/genetics
;
Feces/*microbiology
;
Humans
;
Multiplex Polymerase Chain Reaction
;
Prospective Studies
;
Real-Time Polymerase Chain Reaction
;
Triose-Phosphate Isomerase/genetics
9.Advances in receptor-mediated resistance mechanisms of Lepidopteran insects to Bacillus thuringiensis toxin.
Leilei LIU ; Peiwen XU ; Kaiyu LIU ; Wei WEI ; Zhongshen CHANG ; Dahui CHENG
Chinese Journal of Biotechnology 2022;38(5):1809-1823
Bacillus thuringiensis is widely used as an insecticide which is safe and environmentally friendly to humans and animals. One of the important insecticidal mechanisms is the binding of Bt toxins to specific toxin receptors in insect midgut and forming a toxin perforation which eventually leads to insect death. The resistance of target pests to Bt toxins is an important factor hampering the long-term effective cultivation of Bt crops and the continuous use of Bt toxins. This review summarizes the mechanism of insect resistance to Bt toxins from the perspective of important Bt toxin receptors in midgut cells of Lepidopteran insects, which may facilitate the in-depth study of Bt resistance mechanism and pest control.
Animals
;
Bacillus thuringiensis/genetics*
;
Bacillus thuringiensis Toxins
;
Bacterial Proteins/metabolism*
;
Endotoxins/metabolism*
;
Hemolysin Proteins/metabolism*
;
Insecta/metabolism*
;
Insecticide Resistance/genetics*
;
Insecticides/pharmacology*
;
Pest Control, Biological
10.Fusion expression of Escherichia coli heat-labile enterotoxin B subunit gene and foot-and-mouth disease virus type O VP1 gene and immunogenicity analysis.
Runcheng LI ; Xinglong YU ; Xia BAI ; Weijun XIANG ; Meng GE ; Manxiang LI
Chinese Journal of Biotechnology 2009;25(4):560-565
LTB gene fragment was amplified by PCR from plasmid pMDTLT, and a recombinant plasmid pETLTBVP1 was constructed by inserting LTB gene fragment into VP1 gene expression plasmid pETVP1 constructed previously. The recombinant plasmids were transformed into E. coli BL21(DE3) and induced to express by IPTG. The recombinant protein existed in the inclusion body and its molecular weight was about 39 kD proved by SDS-PAGE analysis. Western blotting showed that the fusion protein could be reacted with both anti-FMDV and anti-cholera toxin serum demonstrating the immunoactivity of the fusion protein. Strong immune responses can be induced in mice inoculated with the fusion protein intraperitoneally, and the serum antibody level is higher than that of commercial foot-and-mouth disease vaccines.
Animals
;
Antibodies, Viral
;
blood
;
Bacterial Toxins
;
genetics
;
immunology
;
metabolism
;
Capsid Proteins
;
genetics
;
immunology
;
metabolism
;
Enterotoxins
;
genetics
;
immunology
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Escherichia coli Proteins
;
Female
;
Gene Fusion
;
genetics
;
Mice
;
Plasmids
;
genetics
;
Recombinant Fusion Proteins
;
genetics
;
immunology
;
metabolism